Cantel Medical Corp.
(NYSE: CMD)
Rigrodsky Law, P.A. is investigating Cantel Medical Corp. (“Cantel”) regarding possible breaches of fiduciary duties and other violations of law related to Cantel’s agreement to be acquired by STERIS plc (“STERIS”). Under the terms of the agreement, Cantel’s shareholders will receive approximately $16.93 in cash and 0.33787 of a share of STERIS per share.